Utah Retirement Systems Amgen Inc Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Amgen Inc stock. As of the latest transaction made, Utah Retirement Systems holds 88,761 shares of AMGN stock, worth $24.9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

88,761

Previous 88,361 0.45%

Holding current value

$24.9 Million

Previous $27.6 Million 3.59%

% of portfolio

0.33%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $123,752 - $134,952	400 Added 0.45%	88,761 $28.6 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $1.13 Million - $1.37 Million	-4,300 Reduced 4.64%	88,361 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $127,850 - $144,230	500 Added 0.54%	92,661 $26.7 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $109,325 - $135,730	500 Added 0.55%	92,161 $24.8 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $749,945 - $886,795	-3,500 Reduced 3.68%	91,661 $20.4 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $67,737 - $82,560	300 Added 0.32%	95,161 $23 Million
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $214,372 - $272,385	-936 Reduced 0.98%	94,861 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $112,230 - $126,575	500 Added 0.52%	95,797 $21.6 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $1.02 Million - $1.13 Million	-4,400 Reduced 4.41%	95,297 $23.2 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $745,518 - $824,738	-3,400 Reduced 3.3%	99,697 $24.1 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $59,664 - $68,280	300 Added 0.29%	103,097 $23.2 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $1.44 Million - $1.69 Million	-6,800 Reduced 6.2%	102,797 $21.9 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $537,234 - $596,022	-2,300 Reduced 2.06%	109,597 $26.7 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.09 Million - $1.27 Million	-4,900 Reduced 4.2%	111,897 $27.8 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $822,244 - $979,146	3,800 Added 3.36%	116,797 $26.9 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $187,720 - $208,760	800 Added 0.71%	112,997 $28.7 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $356,058 - $436,932	-1,800 Reduced 1.58%	112,197 $26.5 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 0.35%	113,997 $23.1 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $75,684 - $97,280	400 Added 0.35%	114,397 $27.6 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $400,453 - $479,826	-2,300 Reduced 1.98%	113,997 $22.1 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $457,258 - $536,009	-2,743 Reduced 2.3%	116,297 $21.4 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $232,960 - $262,597	-1,288 Reduced 1.07%	119,040 $22.6 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 0.08%	120,328 $23.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $407,638 - $459,557	-2,200 Reduced 1.79%	120,428 $25 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1.96 Million - $2.2 Million	-11,800 Reduced 8.78%	122,628 $22.6 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $423,575 - $495,000	-2,500 Reduced 1.83%	134,428 $22.9 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $320,701 - $358,321	1,900 Added 1.41%	136,928 $23.8 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $22.6 Million - $25.8 Million	135,028	135,028 $25.2 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Amgen Inc Transaction History